Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 23Recruiting 8Unknown 4Terminated 4Withdrawn 2Active not recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Motor Activity 2Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × High-Intensity Interval Training × Clear all
NCT05156372 2024-02-26

HIIT PCa

The University of Texas Health Science Center at San Antonio

Phase NA Withdrawn
Genitourinary

Motor Activity, Prostatic Neoplasms

NCT03176888 2020-03-25

Health Benefits of HIT for Breast Cancer Patients

University of Stirling

Phase NA Withdrawn
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡